XOMA Announces Stock Repurchase Program of up to $50 Million

 XOMA Corporation (Nasdaq: XOMA), the biotech royalty aggregator, today announced its Board of Directors has authorized XOMA’s first stock repurchase program, which permits the Company to purchase up to $50 million of XOMA’s common stock through January 2027.  

https://www.globenewswire.com/news-release/2024/01/02/2802594/7281/en/XOMA-Announces-Stock-Repurchase-Program-of-up-to-50-Million.html